Shuttle Unique Capabilities!

Bobby Martin shared REAL Space Act of 2013's photo.

Just now · 

As our experts have stated, the many unique capabilities of shuttle plus the maintenance of our skills are lost, As clearly indicated by nasaproblems.com , Don Nelson , all this manned space flight down time coupled with China' s intent to have an operational reuseable shuttle, clearly places the USA in serious situation! YET, the media will not bring facts to the people! Spread the word!!

REAL Space Act of 2013

Never should have been retired!

###

Did you know that United Space Alliance (USA) submitted a proposal to fly the shuttles as a commercial service for NASA?

...See More

Sent from my iPad

Crazy pro abortion professor at uscsb

Professor at uscsb stealing prolife signs & acted like the prolife students were nuts.

Fwd: Astounding

Sent from my iPad

Begin forwarded message:

From: "Jay Sekulow, ACLJ Chief Counsel" <jay.sekulow@email.aclj.org>
Date: November 28, 2014 at 3:40:46 PM CST
To: <bobbygmartin1938@gmail.com>
Subject: Astounding
Reply-To: "American Center for Law and Justice" <reply-fed416717566047b-88_HTML-468316-6234688-73@email.aclj.org>

To view this email as a web page, go here.

Doctors forced by anti-life laws?

Take Action  |   Contribute   Like     f   Like this on Facebook   Bobby, Big abortion's attack on life is astounding. This month, we've taken on abortion radicals in courts nationwide. When the abortion industry tried to strike down a lifesaving law in Texas, we filed a critical amicus brief. Our attorneys cut through abortion industry deception and helped a pro-life law pass in Tennessee. We recently filed two lawsuits to stop a city from silencing and prosecuting pro-life counselors and to protect a doctor from being forced to dispense abortion pills. We're continuing our fights against the abortion-pill mandate and to protect pro-life pregnancy centers. Together we're saving lives. But we can't continue our pro-life work without your support. Tomorrow is the deadline for our critical November Matching Challenge. Any amount you give will be doubled. But we're still over $295,378 short of our goal. Defend Life. Have Your Tax-Deductible Gift Doubled Today. Jay Sekulow ACLJ Chief Counsel Contribute Now Double Your Gift Like     f   Like this on Facebook   To ensure that you continue to receive e-mails from the ACLJ, please add jay.sekulow@email.aclj.org to your address book.     Connect to ACLJ Facebook Twitter YouTube Connect to Jay Sekulow Facebook Twitter YouTube Connect to Our Apps iPhone App iPad App The ACLJ is an organization dedicated to the defense of constitutional liberties secured by law. American Center for Law and Justice is a d/b/a for Christian Advocates Serving Evangelism, Inc., a tax-exempt, not-for-profit, religious corporation as defined under Section 501(c)(3) of the Internal Revenue Code, specifically dedicated to the ideal that religious freedom and freedom of speech are inalienable, God-given rights. The Center's purpose is to engage legal, legislative and cultural issues by implementing an effective strategy of advocacy, education and litigation to ensure that those rights are protected under the law. The organization has participated in numerous cases before the Supreme Court, Federal Court of Appeals, Federal District Courts, and various state courts regarding freedom of religion and freedom of speech. Your gift is very much appreciated and fully deductible as a charitable contribution. A copy of our latest financial report may be obtained by writing to us at P.O. Box 90555, Washington, DC 20090-0555. As always, let us know of threats to freedom in your area by calling (757) 226-2489. And tune in to our daily radio program, "Jay Sekulow Live!" Do not send a response message to this e-mail for any reason. Legal requests will not be answered through jsekulow@aclj.org. Legal requests must be submitted at ACLJ.org. HOW CAN I SUPPORT THE AMERICAN CENTER FOR LAW AND JUSTICE? Make a secure online donation. For other ways to support the ACLJ at no additional cost to you, go here. Copyright © 2014, ACLJ | Privacy & Security Policy | Unsubscribe

Fwd: Google Alert - patient temperature management

Sent from my iPad

Begin forwarded message:

From: Google Alerts <googlealerts-noreply@google.com>
Date: November 24, 2014 9:17:01 PM CST
To: bobbygmartin1938@gmail.com
Subject: Google Alert - patient temperature management

	patient temperature management Daily update ⋅ November 25, 2014
	NEWS
	ZOLL Files with Japan's Pharmaceuticals and Medical Devices Agency for New Indication for ... Newswire Today (press release) "Use of temperature management for sudden cardiac arrest is ... by directly cooling or warming the patient's blood as it flows through the body. Flag as irrelevant
Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback

This Crazy potus is destroying our space capabilities--- get the facts email, tweet foxnews personalities until we get the facts out!!! Your country depends on YOU!!!!

Please help, we needs a strong space program for National Security, also help the economy & assures we have the technical capabilities in the workforce.

Get with it& stay at it!!!!! Your FREEDOM depends on it!!!

Bobby Martin
Bobbygmartin1938@gmail.com

Fwd: Google Alert - patient temperature management

Sent from my iPad

Begin forwarded message:

From: Google Alerts <googlealerts-noreply@google.com>
Date: November 11, 2014 9:00:17 PM CST
To: bobbygmartin1938@gmail.com
Subject: Google Alert - patient temperature management

	patient temperature management Daily update ⋅ November 12, 2014
	NEWS
	ZOLL to Showcase Advanced Resuscitation Technology for Improving CPR Quality At Medica 2014 Newswire Today (press release) The LifeVest is lightweight and easy to wear, and allows a patient's ... ZOLL's Intravascular Temperature Management (IVTM™) System offers health ... Flag as irrelevant
Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback

Fwd: Rare Genetic Disease Protects Against Bipolar Disorder; Combating Bladder Cancer With Approved Drug

Sent from my iPad

Begin forwarded message:

From: Kent Castle <kent.d.castle@hotmail.com>
Date: October 14, 2014 4:55:46 PM CDT
To: Choban Peter <peter.s.choban@aero.org>, Reason Marilou <loganlou55@yahoo.com>, Astrology Valkyrie <astrogoddess@valkyrieastrology.com>, Patterson James <w8ljz@aol.com>, Martin Bobby <bobbygmartin1938@gmail.com>, Chamberlain Sharon <sharon.m.chamberlain@saic.com>, Carman Gilbert <gil77546@sbcglobal.net>, Schwering Suanne <suannesch@mac.com>, Sutherland Aurora <fuentesd11@yahoo.com>, Bentz Jerry <bentz@sbcglobal.net>, Arnold Jenny <arnoldrj@bellsouth.net>, Brown Paul <paul.brown1@yahoo.com>, Grant Berl <berlgrant@frontier.com>, Bilger Boyd <boyd.bilger@embarqmail.com>, Books Mark <mebooks2012@gmail.com>, Lozano Marianne <kemahsabe@comcast.net>, "lrodriguez@neighborhood-centers.org" <lrodriguez@neighborhood-centers.org>
Subject: FW: Rare Genetic Disease Protects Against Bipolar Disorder; Combating Bladder Cancer With Approved Drug

 

---

From: reply@mail.dddmag.com
To: KENT.D.CASTLE@HOTMAIL.COM
Subject: Rare Genetic Disease Protects Against Bipolar Disorder; Combating Bladder Cancer With Approved Drug
Date: Tue, 14 Oct 2014 13:01:27 -0600

Astellas Collaborates with Harvard for Retinal Degeneration Treatment; Rats of New York and The Diseases They Carry

View this email in your browser. OCT 14 IN THIS ISSUE   NEWS     Combating Bladder Cancer With Approved Drug     NEWS     Astellas Collaborates with Harvard for Retinal Degeneration Treatment     NEWS     Rats of New York and The Diseases They Carry     NEWS     Biologists Find Gene That Could Stop Tumors in Their Tracks     NEWS     Medtronic Begins Study of First Predictive Low Glucose Management Technology   Weldable, Sealable BioPharma Tubing - Get a Sample AdvantaFlex® TPE tubing welds, seals and molds into fittings to reduce leaks. No silicone oils or animal derived components; fewer extractables than other tubing. Made in USA. COMPLIMENTARY SAMPLE FEATURED STORY Rare Genetic Disease Protects Against Bipolar Disorder A team of scientists led by researchers at the UMass Medical School and UMMSM have identified what is likely a key genetic pathway underlying bipolar disorder, a breakthrough that could lead to better drugs for treating bipolar affective disorder, as well as depression and other related mood disorders. Read more... Share FULL STORY Versatile Evaporator for Lab & Batch Processing Tasks The Genevac Rocket Synergy Series sets a new benchmark in evaporation versatility. The system is able to dry or concentrate up to six 450ml flasks, or 18 ASE® vials, and with a simple rotor switch enable unattended automated batch processing of up to 100 litres per run. FURTHER INFO NEWS Combating Bladder Cancer With Approved Drug A drug that activates targets of the hedgehog signaling pathway, which is lost when bladder cancer invades, could prevent the progression of the disease in humans. Clinical trials are planned. Read more...                   FULL STORY NEWS Astellas Collaborates with Harvard for Retinal Degeneration Treatment Astellas Pharma Inc. announced a research collaboration with an investigator at Harvard focused on discovering the pathologic mechanism for retinitis pigmentosa and identification of new therapeutic targets. Read more... FULL STORY Biofluid miRNA Profiling: From Sample to Biomarker Join us for a free, educational webcast, as Senior Director of Product Development, Dr. Eric Lader leads an in-depth discussion of: • miRNA Profiling of biofluid samples • miRNA biomarker discovery • supporting data for sample to biomarker miRNA analysis LEARN MORE NEWS Rats of New York and The Diseases They Carry In the first study to look at would-be diseases carried by New York City rats, scientists at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health identified bacterial pathogens, including E. coli, Salmonella, and C. difficile, that cause mild to life-threatening gastroenteritis in people. Read more... FULL STORY NEWS Biologists Find Gene That Could Stop Tumors in Their Tracks The dirt in your backyard may hold the key to isolating cancerous tumors and to potential new treatments for a host of cancers. Read more...                                          FULL STORY NEWS Medtronic Begins Study of First Predictive Low Glucose Management Technology Medtronic Inc. announced that the first patients have been enrolled in an investigational device exemption (IDE) study of its breakthrough Predictive Low Glucose Management (PLGM) technology, marking a critical step toward development of an artificial pancreas in the U.S. market. Read more... FULL STORY SUBSCRIBE • UNSUBSCRIBE • ABOUT US • ADVERTISE This email was sent by: Drug Discovery & Development 100 Enterprise Drive - Suite 600 - Rockaway, NJ 07866-2129 We respect your right to privacy - click here to view our policy. ©2014 Drug Discovery & Development. All rights reserved.